RenovoRx RNXT 深 滬
等待開盤 10-28 09:30:00 美东时间
1.39
+0.080
+6.11%
華盛通- 最 高1.43
- 今 開1.33
- 成交量 28.94万股
- 最 低 1.30
- 昨 收 1.31
- 總市值 6273.00万
- 52周最高 2.59
- 市盈率 靜 --
- 換手率 0.64%
- 52周最低 0.7006
- 委 比 -41.59%
- 總股本 4512.95万
- 歷史最高 16.74
- 量 比 1.06
- 振 幅 9.92%
- 歷史最低 0.5306
- 每 手 1
- 風險率 0.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多RNXT收涨1.55%，成交额23.73万美元
10月27日，RNXT（RNXT）收涨1.55%，报1.31美元，成交额23.73万美元，市值5911.92万美元。 行情数据 • 开盘价：1.3美元 • 最高...
10-27 07:19
RNXT收跌4.2%，成交额32.5万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:27
RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center
RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced the publication of a peer-reviewed case series in Case Reports in Oncol...
10-01 20:39
These low-priced stocks are flashing overbought signals
Several sub-$10 stocks are flashing elevated momentum signals, with a handful already entering traditionally overbought territory as recent rallies push their Relative Strength Index readings toward t...
09-05 00:19
The best Quant-rated stocks trading below $10 right now
Seeking Alpha's Quant Rating system has identified a fresh group of sub-$10 stocks that rank among the highest-rated names in its universe, underscoring that low-priced shares can still exhibit strong...
09-04 18:51
美股前瞻 | 苹果换帅！库克明日正式卸任；美伊互袭，油价急涨4%！三大期指齐挫；SK海力士被曝考虑英特尔代工
苹果换帅！库克明日正式卸任；美伊互袭，油价急涨4%！三大期指齐挫；HBM供应链生变？SK海力士被曝考虑英特尔代工>>
08-31 20:16
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $14.5
Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $14 to $14.5.
08-28 18:50
RenovoRx regains Nasdaq compliance
RenovoRx (RNXT) announced on Friday that it has received a Nasdaq notification, confirming that the company has regained compliance with the minimum bid price requirement for continued listing on the ...
08-21 21:12
RenovoRx Earnings Call: Record Growth, Rising Risks
Renovorx, Inc. (($RNXT)) has held its Q2 earnings call. Read on for the main hi...
08-21 08:27
